Showing 321-340 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Granulocyte‐colony stimulating factors as adjunctive therapy for diabetic foot infections
Cochrane Systematic Reviews, 17-Aug-2013
Granulocyte-colony stimulating factor (G-CSF) increases the release of neutrophil endothelial progenitor cells from the bone marrow and improves neutrophil functions, which are often impaired in people with diabetes.
- Granulopoiesis‐stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Cochrane Systematic Reviews, 8-Oct-2008
Granulopoiesis-stimulating factors, such as granulocyte-colony-stimulating factor (G-CSF) and granulocyte-macrophage-colony-stimulating factor (GM-CSF), are being used to prevent febrile neutropenia and infection in patients undergoing treatment for malig
- H1‐antihistamines for the treatment of anaphylaxis with and without shock
Cochrane Systematic Reviews, 24-Jan-2007
Anaphylaxis is an acute systemic allergic reaction, which can be life-threatening. H1-antihistamines are commonly used as an adjuvant therapy in the treatment of anaphylaxis.
- Haloperidol alone or in combination for acute mania
Cochrane Systematic Reviews, 12-May-2009
The main objectives in treating mania are to control dangerous behaviour, reduce suicide, produce appropriate acute sedation and shorten the episode of mood disturbance. Among different drugs, haloperidol has for many years been used in treating psychotic
- Haloperidol versus chlorpromazine for schizophrenia
Cochrane Systematic Reviews, 31-Jan-2013
Chlorpromazine and haloperidol are benchmark antipsychotic drugs. Both are said to be equally effective when used at equivalent doses, but have different side-effect profiles.
- Haloperidol versus placebo for schizophrenia
Cochrane Systematic Reviews, 5-Nov-2013
Haloperidol was developed in the late 1950s for use in the field of anaesthesia. Research subsequently demonstrated effects on hallucinations, delusions, aggressiveness, impulsiveness and states of excitement and led to the introduction of haloperidol as
- Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
Cochrane Systematic Reviews, 20-Sep-2010
Peptic ulcer is the main cause for upper gastrointestinal haemorrhage, and Helicobacter pylori (H.pylori) infection is the main etiologic factor for peptic ulcer disease. Maintenance antisecretory therapy is the standard long-term treatment for patients w
- Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 22-Jan-2001
Due to its low density properties, helium-oxygen mixtures have the potential to decrease the work of breathing and possibly avoid the need for intubation and mechanical ventilation in patients with respiratory failure.
- Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
Cochrane Systematic Reviews, 21-Oct-2002
Hip fracture patients have a high risk of thrombo-embolic complications following surgical management.
- Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Cochrane Systematic Reviews, 25-Feb-2014
Central venous catheters (CVCs) are a mainstay in the management of critically ill children. However, these catheters are associated with mechanical and infectious complications which reduce their life span. Heparin bonding of catheters has shown promise
- Herbal medicines for treating HIV infection and AIDS
Cochrane Systematic Reviews, 20-Jul-2005
HIV-infected people and AIDS patients often seek complementary therapies including herbal medicines due to reasons such as unsatisfactory effects, high cost, non-availability, or adverse effects of conventional medicines.
- High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
Cochrane Systematic Reviews, 19-Apr-2004
Inhaled corticosteroids (ICS) form the basis of maintenance therapy in asthma and their efficacy is well established. However, the optimal starting dose of ICS is not clearly established. Recent reviews demonstrate a relatively flat efficacy curve for ICS
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
Cochrane Systematic Reviews, 20-May-2016
Overall survival rates are disappointing for women with early poor prognosis breast cancer. Autologous transplantation of bone marrow or peripheral stem cells (in which the woman is both donor and recipient) has been considered a promising technique becau
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
Cochrane Systematic Reviews, 20-Jul-2005
Although metastatic breast cancer is often responsive to conventional chemotherapy, it remains ultimately incurable. Autologous transplantation of bone marrow or peripheral stem cells (in which the patient is both donor and recipient) has been considered
- HMG CoA reductase inhibitors (statins) for dialysis patients
Cochrane Systematic Reviews, 2-Sep-2013
People with advanced kidney disease treated with dialysis experience mortality rates from cardiovascular disease that are substantially higher than for the general population. Studies that have assessed the benefits of statins (HMG CoA reductase inhibitor
- Holding chambers versus nebulisers for inhaled steroids in chronic asthma
Cochrane Systematic Reviews, 25-Jan-2006
Inhaled corticosteroids are available in the form of a suspension for nebulisation, although the role of this mode of therapy in the treatment of chronic asthma is still unclear.
- Home versus in‐patient treatment for deep vein thrombosis
Cochrane Systematic Reviews, 9-Jan-2018
Deep vein thrombosis (DVT) occurs when a blood clot blocks blood flow through a vein, which can occur after surgery, after trauma, or when a person has been immobile for a long time. Clots can dislodge and block blood flow to the lungs (pulmonary embolism
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
Cochrane Systematic Reviews, 12-Dec-2012
Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review ori
- Ibuprofen for Alzheimer's disease
Cochrane Systematic Reviews, 13-May-2008
Non-steroidal antiinflammatory drugs such as ibuprofen may have a role in the treatment of conditions characterized by inflammatory processes. Ibuprofen may attenuate the effects of modulators of inflammation that have been implicated in the pathogenesis
- Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
Cochrane Systematic Reviews, 9-Dec-2016
Carbamazepine (CBZ) is a commonly used drug for epilepsy that is associated with troublesome adverse events including dizziness, double vision, drowsiness, poor co-ordination and unsteadiness. These adverse events often occur during peaks in drug plasma c
